CCBS — Castle Creek Biosciences Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Castle Creek Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 57.2 | 20.6 |
| Prepaid Expenses | ||
| Total Current Assets | 58.4 | 23.1 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 2.18 | 3.48 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 61.8 | 27.9 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 28.5 | 2.71 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 29.3 | 23 |
| Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 32.5 | 4.9 |
| Total Liabilities & Shareholders' Equity | 61.8 | 27.9 |
| Total Common Shares Outstanding |